Cargando…
Therapeutic targeting of prenatal pontine ID1 signaling in diffuse midline glioma
BACKGROUND: Diffuse midline gliomas (DMG) are highly invasive brain tumors with rare survival beyond two years past diagnosis and limited understanding of the mechanism behind tumor invasion. Previous reports demonstrate upregulation of the protein ID1 with H3K27M and ACVR1 mutations in DMG, but thi...
Autores principales: | Messinger, Dana, Harris, Micah K, Cummings, Jessica R, Thomas, Chase, Yang, Tao, Sweha, Stefan R, Woo, Rinette, Siddaway, Robert, Burkert, Martin, Stallard, Stefanie, Qin, Tingting, Mullan, Brendan, Siada, Ruby, Ravindran, Ramya, Niculcea, Michael, Dowling, Abigail R, Bradin, Joshua, Ginn, Kevin F, Gener, Melissa A H, Dorris, Kathleen, Vitanza, Nicholas A, Schmidt, Susanne V, Spitzer, Jasper, Li, Jiang, Filbin, Mariella G, Cao, Xuhong, Castro, Maria G, Lowenstein, Pedro R, Mody, Rajen, Chinnaiyan, Arul, Desprez, Pierre-Yves, McAllister, Sean, Dun, Matthew D, Hawkins, Cynthia, Waszak, Sebastian M, Venneti, Sriram, Koschmann, Carl, Yadav, Viveka Nand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825316/ https://www.ncbi.nlm.nih.gov/pubmed/35605606 http://dx.doi.org/10.1093/neuonc/noac141 |
Ejemplares similares
-
EPCT-07. ID1 IS A KEY TRANSCRIPTIONAL REGULATOR OF DIPG INVASION AND IS TARGETABLE WITH CANNABIDIOL
por: Nand Yadav, Viveka, et al.
Publicado: (2021) -
DIPG-59. UPREGULATION OF PRENATAL PONTINE ID1 SIGNALING IN DIPG
por: Harris, Micah K, et al.
Publicado: (2020) -
Multi-focal sequencing of a diffuse intrinsic pontine glioma establishes PTEN loss as an early event
por: Koschmann, Carl, et al.
Publicado: (2017) -
BRAF activating mutations involving the β3-αC loop in V600E-negative anaplastic pleomorphic xanthoastrocytoma
por: Pratt, Drew, et al.
Publicado: (2018) -
Receptor tyrosine kinase (RTK) targeting in pediatric high-grade glioma and diffuse midline glioma: Pre-clinical models and precision medicine
por: Schwark, Kallen, et al.
Publicado: (2022)